Study title: Eformoterol versus salmeterol: reduction in short acting bronchodilator usage in asthmatic children treated with inhaled steroids: FACT.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FORMOTEROL | |||||
ATC code: R03AC13 | |||||
Document link: BU-037-0004 Study Synopsis.pdf | |||||
Document date: 2011-11-22 | |||||
Study number: BU-037-CR-0004 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |